Shares of oncology company Exelixis, Inc. (EXEL) are higher by 177% since 2017.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
Alpaca · SIPUpdated 19:46 NY15 Minutes Delayed
S&P 500, Nasdaq Jump On Chipmaker Strength As Investors Eye October Fed Decision — ORCL, HOOD, JBLU, RIVN, SMCI In Focus
Yahoo3 Hours Ago
SK hynix Announces 3Q26 Financial Results
Yahoo3 Hours Ago
Ecolab (ECL) Q3 2026 Earnings Call Transcript
Yahoo3 Hours Ago
Argus Research Downgrades Abbott Laboratories to Hold from Buy
Fintel3 Hours Ago
He Left Uber to Fix Farming's Billion-Dollar Problem
Yahoo3 Hours Ago
